nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—CYP2E1—Fingolimod—multiple sclerosis	0.114	0.156	CbGbCtD
Zafirlukast—ABCG2—Cladribine—multiple sclerosis	0.103	0.141	CbGbCtD
Zafirlukast—ABCG2—Mitoxantrone—multiple sclerosis	0.0751	0.103	CbGbCtD
Zafirlukast—CYP2D6—Fingolimod—multiple sclerosis	0.0543	0.0742	CbGbCtD
Zafirlukast—CYP2E1—Mitoxantrone—multiple sclerosis	0.0535	0.0732	CbGbCtD
Zafirlukast—ABCG2—Dexamethasone—multiple sclerosis	0.0389	0.0532	CbGbCtD
Zafirlukast—CYP3A4—Fingolimod—multiple sclerosis	0.0345	0.0472	CbGbCtD
Zafirlukast—ABCG2—Methotrexate—multiple sclerosis	0.0313	0.0428	CbGbCtD
Zafirlukast—CYP2C19—Prednisone—multiple sclerosis	0.0279	0.0381	CbGbCtD
Zafirlukast—CYP2E1—Dexamethasone—multiple sclerosis	0.0278	0.0379	CbGbCtD
Zafirlukast—CYP3A4—Methylprednisolone—multiple sclerosis	0.0222	0.0304	CbGbCtD
Zafirlukast—CYP2C8—Dexamethasone—multiple sclerosis	0.0207	0.0283	CbGbCtD
Zafirlukast—CYP2C19—Dexamethasone—multiple sclerosis	0.0174	0.0238	CbGbCtD
Zafirlukast—CYP3A4—Triamcinolone—multiple sclerosis	0.0169	0.023	CbGbCtD
Zafirlukast—CYP3A4—Mitoxantrone—multiple sclerosis	0.0162	0.0222	CbGbCtD
Zafirlukast—CYP2C9—Dexamethasone—multiple sclerosis	0.0145	0.0198	CbGbCtD
Zafirlukast—CYP3A4—Betamethasone—multiple sclerosis	0.0145	0.0198	CbGbCtD
Zafirlukast—CYP3A4—Prednisolone—multiple sclerosis	0.0143	0.0195	CbGbCtD
Zafirlukast—CYP3A4—Prednisone—multiple sclerosis	0.0135	0.0184	CbGbCtD
Zafirlukast—CYP2D6—Dexamethasone—multiple sclerosis	0.0132	0.0181	CbGbCtD
Zafirlukast—CYP3A4—Dexamethasone—multiple sclerosis	0.00841	0.0115	CbGbCtD
Zafirlukast—Glyburide—SLC15A2—multiple sclerosis	0.0021	0.823	CrCbGaD
Zafirlukast—Haemorrhage—Prednisolone—multiple sclerosis	0.000459	0.0027	CcSEcCtD
Zafirlukast—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000452	0.00266	CcSEcCtD
Zafirlukast—Glyburide—ALB—multiple sclerosis	0.000452	0.177	CrCbGaD
Zafirlukast—Hepatic failure—Methotrexate—multiple sclerosis	0.000448	0.00264	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000448	0.00263	CcSEcCtD
Zafirlukast—Hypersensitivity—Cladribine—multiple sclerosis	0.000446	0.00262	CcSEcCtD
Zafirlukast—Malaise—Mitoxantrone—multiple sclerosis	0.000439	0.00258	CcSEcCtD
Zafirlukast—Asthenia—Cladribine—multiple sclerosis	0.000434	0.00255	CcSEcCtD
Zafirlukast—Pruritus—Cladribine—multiple sclerosis	0.000428	0.00252	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000425	0.0025	CcSEcCtD
Zafirlukast—Haemoglobin—Triamcinolone—multiple sclerosis	0.000424	0.00249	CcSEcCtD
Zafirlukast—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000423	0.00249	CcSEcCtD
Zafirlukast—Haemorrhage—Triamcinolone—multiple sclerosis	0.000422	0.00248	CcSEcCtD
Zafirlukast—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000421	0.00248	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000418	0.00246	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000418	0.00246	CcSEcCtD
Zafirlukast—Myalgia—Mitoxantrone—multiple sclerosis	0.000415	0.00244	CcSEcCtD
Zafirlukast—Arthralgia—Mitoxantrone—multiple sclerosis	0.000415	0.00244	CcSEcCtD
Zafirlukast—Diarrhoea—Cladribine—multiple sclerosis	0.000414	0.00243	CcSEcCtD
Zafirlukast—Discomfort—Mitoxantrone—multiple sclerosis	0.00041	0.00241	CcSEcCtD
Zafirlukast—Feeling abnormal—Azathioprine—multiple sclerosis	0.000405	0.00238	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000402	0.00236	CcSEcCtD
Zafirlukast—Dizziness—Cladribine—multiple sclerosis	0.0004	0.00235	CcSEcCtD
Zafirlukast—Oedema—Mitoxantrone—multiple sclerosis	0.000398	0.00234	CcSEcCtD
Zafirlukast—Infection—Mitoxantrone—multiple sclerosis	0.000395	0.00232	CcSEcCtD
Zafirlukast—Neutropenia—Prednisone—multiple sclerosis	0.00039	0.00229	CcSEcCtD
Zafirlukast—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000389	0.00229	CcSEcCtD
Zafirlukast—Abdominal pain—Azathioprine—multiple sclerosis	0.000389	0.00228	CcSEcCtD
Zafirlukast—Body temperature increased—Azathioprine—multiple sclerosis	0.000389	0.00228	CcSEcCtD
Zafirlukast—Haemoglobin—Betamethasone—multiple sclerosis	0.000385	0.00226	CcSEcCtD
Zafirlukast—Haemoglobin—Dexamethasone—multiple sclerosis	0.000385	0.00226	CcSEcCtD
Zafirlukast—Vomiting—Cladribine—multiple sclerosis	0.000385	0.00226	CcSEcCtD
Zafirlukast—Haemorrhage—Betamethasone—multiple sclerosis	0.000383	0.00225	CcSEcCtD
Zafirlukast—Haemorrhage—Dexamethasone—multiple sclerosis	0.000383	0.00225	CcSEcCtD
Zafirlukast—Rash—Cladribine—multiple sclerosis	0.000381	0.00224	CcSEcCtD
Zafirlukast—Dermatitis—Cladribine—multiple sclerosis	0.000381	0.00224	CcSEcCtD
Zafirlukast—Headache—Cladribine—multiple sclerosis	0.000379	0.00223	CcSEcCtD
Zafirlukast—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000372	0.00219	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000371	0.00218	CcSEcCtD
Zafirlukast—Angioedema—Prednisolone—multiple sclerosis	0.000365	0.00215	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000364	0.00214	CcSEcCtD
Zafirlukast—Hypersensitivity—Azathioprine—multiple sclerosis	0.000362	0.00213	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000362	0.00213	CcSEcCtD
Zafirlukast—Malaise—Prednisolone—multiple sclerosis	0.00036	0.00212	CcSEcCtD
Zafirlukast—Nausea—Cladribine—multiple sclerosis	0.000359	0.00211	CcSEcCtD
Zafirlukast—Back pain—Triamcinolone—multiple sclerosis	0.000355	0.00209	CcSEcCtD
Zafirlukast—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00035	0.00206	CcSEcCtD
Zafirlukast—Eosinophilia—Methotrexate—multiple sclerosis	0.000345	0.00203	CcSEcCtD
Zafirlukast—Fatigue—Mitoxantrone—multiple sclerosis	0.000343	0.00201	CcSEcCtD
Zafirlukast—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000341	0.002	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.00034	0.002	CcSEcCtD
Zafirlukast—Pain—Mitoxantrone—multiple sclerosis	0.00034	0.002	CcSEcCtD
Zafirlukast—Diarrhoea—Azathioprine—multiple sclerosis	0.000336	0.00198	CcSEcCtD
Zafirlukast—Discomfort—Prednisolone—multiple sclerosis	0.000336	0.00198	CcSEcCtD
Zafirlukast—Angioedema—Triamcinolone—multiple sclerosis	0.000336	0.00197	CcSEcCtD
Zafirlukast—Haemoglobin—Prednisone—multiple sclerosis	0.000335	0.00197	CcSEcCtD
Zafirlukast—Angioedema—Methylprednisolone—multiple sclerosis	0.000335	0.00197	CcSEcCtD
Zafirlukast—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000334	0.00196	CcSEcCtD
Zafirlukast—Haemorrhage—Prednisone—multiple sclerosis	0.000334	0.00196	CcSEcCtD
Zafirlukast—Malaise—Triamcinolone—multiple sclerosis	0.000331	0.00195	CcSEcCtD
Zafirlukast—Malaise—Methylprednisolone—multiple sclerosis	0.000331	0.00194	CcSEcCtD
Zafirlukast—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000328	0.00193	CcSEcCtD
Zafirlukast—Oedema—Prednisolone—multiple sclerosis	0.000326	0.00192	CcSEcCtD
Zafirlukast—Neutropenia—Methotrexate—multiple sclerosis	0.000326	0.00191	CcSEcCtD
Zafirlukast—Dizziness—Azathioprine—multiple sclerosis	0.000325	0.00191	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000325	0.00191	CcSEcCtD
Zafirlukast—Urticaria—Mitoxantrone—multiple sclerosis	0.000316	0.00186	CcSEcCtD
Zafirlukast—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000314	0.00185	CcSEcCtD
Zafirlukast—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000314	0.00185	CcSEcCtD
Zafirlukast—Myalgia—Triamcinolone—multiple sclerosis	0.000313	0.00184	CcSEcCtD
Zafirlukast—Vomiting—Azathioprine—multiple sclerosis	0.000313	0.00184	CcSEcCtD
Zafirlukast—Arthralgia—Methylprednisolone—multiple sclerosis	0.000312	0.00183	CcSEcCtD
Zafirlukast—Myalgia—Methylprednisolone—multiple sclerosis	0.000312	0.00183	CcSEcCtD
Zafirlukast—Rash—Azathioprine—multiple sclerosis	0.00031	0.00182	CcSEcCtD
Zafirlukast—Dermatitis—Azathioprine—multiple sclerosis	0.00031	0.00182	CcSEcCtD
Zafirlukast—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000309	0.00182	CcSEcCtD
Zafirlukast—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000309	0.00182	CcSEcCtD
Zafirlukast—Discomfort—Triamcinolone—multiple sclerosis	0.000309	0.00182	CcSEcCtD
Zafirlukast—Discomfort—Methylprednisolone—multiple sclerosis	0.000308	0.00181	CcSEcCtD
Zafirlukast—Headache—Azathioprine—multiple sclerosis	0.000308	0.00181	CcSEcCtD
Zafirlukast—Angioedema—Dexamethasone—multiple sclerosis	0.000305	0.00179	CcSEcCtD
Zafirlukast—Angioedema—Betamethasone—multiple sclerosis	0.000305	0.00179	CcSEcCtD
Zafirlukast—Malaise—Dexamethasone—multiple sclerosis	0.000301	0.00177	CcSEcCtD
Zafirlukast—Malaise—Betamethasone—multiple sclerosis	0.000301	0.00177	CcSEcCtD
Zafirlukast—Oedema—Triamcinolone—multiple sclerosis	0.0003	0.00176	CcSEcCtD
Zafirlukast—Infection—Triamcinolone—multiple sclerosis	0.000298	0.00175	CcSEcCtD
Zafirlukast—Infection—Methylprednisolone—multiple sclerosis	0.000297	0.00175	CcSEcCtD
Zafirlukast—Insomnia—Prednisolone—multiple sclerosis	0.000295	0.00173	CcSEcCtD
Zafirlukast—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000293	0.00172	CcSEcCtD
Zafirlukast—Nausea—Azathioprine—multiple sclerosis	0.000292	0.00172	CcSEcCtD
Zafirlukast—Agranulocytosis—Methotrexate—multiple sclerosis	0.00029	0.0017	CcSEcCtD
Zafirlukast—Asthenia—Mitoxantrone—multiple sclerosis	0.000285	0.00168	CcSEcCtD
Zafirlukast—Myalgia—Betamethasone—multiple sclerosis	0.000284	0.00167	CcSEcCtD
Zafirlukast—Myalgia—Dexamethasone—multiple sclerosis	0.000284	0.00167	CcSEcCtD
Zafirlukast—Discomfort—Betamethasone—multiple sclerosis	0.00028	0.00165	CcSEcCtD
Zafirlukast—Discomfort—Dexamethasone—multiple sclerosis	0.00028	0.00165	CcSEcCtD
Zafirlukast—Haemoglobin—Methotrexate—multiple sclerosis	0.00028	0.00165	CcSEcCtD
Zafirlukast—Pain—Prednisolone—multiple sclerosis	0.000279	0.00164	CcSEcCtD
Zafirlukast—Haemorrhage—Methotrexate—multiple sclerosis	0.000279	0.00164	CcSEcCtD
Zafirlukast—Hepatitis—Methotrexate—multiple sclerosis	0.000279	0.00164	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000273	0.00161	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000273	0.0016	CcSEcCtD
Zafirlukast—Oedema—Dexamethasone—multiple sclerosis	0.000272	0.0016	CcSEcCtD
Zafirlukast—Oedema—Betamethasone—multiple sclerosis	0.000272	0.0016	CcSEcCtD
Zafirlukast—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000272	0.0016	CcSEcCtD
Zafirlukast—Insomnia—Triamcinolone—multiple sclerosis	0.000271	0.00159	CcSEcCtD
Zafirlukast—Insomnia—Methylprednisolone—multiple sclerosis	0.000271	0.00159	CcSEcCtD
Zafirlukast—Infection—Betamethasone—multiple sclerosis	0.00027	0.00159	CcSEcCtD
Zafirlukast—Infection—Dexamethasone—multiple sclerosis	0.00027	0.00159	CcSEcCtD
Zafirlukast—Ill-defined disorder—Prednisone—multiple sclerosis	0.000269	0.00158	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisolone—multiple sclerosis	0.000269	0.00158	CcSEcCtD
Zafirlukast—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000266	0.00157	CcSEcCtD
Zafirlukast—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000266	0.00157	CcSEcCtD
Zafirlukast—Angioedema—Prednisone—multiple sclerosis	0.000265	0.00156	CcSEcCtD
Zafirlukast—Dyspepsia—Triamcinolone—multiple sclerosis	0.000264	0.00155	CcSEcCtD
Zafirlukast—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000263	0.00155	CcSEcCtD
Zafirlukast—Malaise—Prednisone—multiple sclerosis	0.000262	0.00154	CcSEcCtD
Zafirlukast—Urticaria—Prednisolone—multiple sclerosis	0.000259	0.00152	CcSEcCtD
Zafirlukast—Fatigue—Triamcinolone—multiple sclerosis	0.000259	0.00152	CcSEcCtD
Zafirlukast—Fatigue—Methylprednisolone—multiple sclerosis	0.000258	0.00152	CcSEcCtD
Zafirlukast—Pain—Triamcinolone—multiple sclerosis	0.000256	0.00151	CcSEcCtD
Zafirlukast—Vomiting—Mitoxantrone—multiple sclerosis	0.000253	0.00149	CcSEcCtD
Zafirlukast—Rash—Mitoxantrone—multiple sclerosis	0.000251	0.00147	CcSEcCtD
Zafirlukast—Dermatitis—Mitoxantrone—multiple sclerosis	0.00025	0.00147	CcSEcCtD
Zafirlukast—Headache—Mitoxantrone—multiple sclerosis	0.000249	0.00146	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000248	0.00146	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000248	0.00146	CcSEcCtD
Zafirlukast—Arthralgia—Prednisone—multiple sclerosis	0.000247	0.00145	CcSEcCtD
Zafirlukast—Myalgia—Prednisone—multiple sclerosis	0.000247	0.00145	CcSEcCtD
Zafirlukast—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000247	0.00145	CcSEcCtD
Zafirlukast—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000247	0.00145	CcSEcCtD
Zafirlukast—Insomnia—Dexamethasone—multiple sclerosis	0.000246	0.00145	CcSEcCtD
Zafirlukast—Insomnia—Betamethasone—multiple sclerosis	0.000246	0.00145	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000245	0.00144	CcSEcCtD
Zafirlukast—Discomfort—Prednisone—multiple sclerosis	0.000244	0.00144	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisolone—multiple sclerosis	0.00024	0.00141	CcSEcCtD
Zafirlukast—Dyspepsia—Dexamethasone—multiple sclerosis	0.00024	0.00141	CcSEcCtD
Zafirlukast—Dyspepsia—Betamethasone—multiple sclerosis	0.00024	0.00141	CcSEcCtD
Zafirlukast—Urticaria—Triamcinolone—multiple sclerosis	0.000238	0.0014	CcSEcCtD
Zafirlukast—Urticaria—Methylprednisolone—multiple sclerosis	0.000238	0.0014	CcSEcCtD
Zafirlukast—Body temperature increased—Triamcinolone—multiple sclerosis	0.000237	0.00139	CcSEcCtD
Zafirlukast—Oedema—Prednisone—multiple sclerosis	0.000237	0.00139	CcSEcCtD
Zafirlukast—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000237	0.00139	CcSEcCtD
Zafirlukast—Nausea—Mitoxantrone—multiple sclerosis	0.000236	0.00139	CcSEcCtD
Zafirlukast—Infection—Prednisone—multiple sclerosis	0.000235	0.00138	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000235	0.00138	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000235	0.00138	CcSEcCtD
Zafirlukast—Back pain—Methotrexate—multiple sclerosis	0.000235	0.00138	CcSEcCtD
Zafirlukast—Fatigue—Dexamethasone—multiple sclerosis	0.000235	0.00138	CcSEcCtD
Zafirlukast—Fatigue—Betamethasone—multiple sclerosis	0.000235	0.00138	CcSEcCtD
Zafirlukast—Pain—Dexamethasone—multiple sclerosis	0.000233	0.00137	CcSEcCtD
Zafirlukast—Pain—Betamethasone—multiple sclerosis	0.000233	0.00137	CcSEcCtD
Zafirlukast—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000225	0.00132	CcSEcCtD
Zafirlukast—Feeling abnormal—Betamethasone—multiple sclerosis	0.000224	0.00132	CcSEcCtD
Zafirlukast—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000224	0.00132	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000223	0.00131	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000223	0.00131	CcSEcCtD
Zafirlukast—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000221	0.0013	CcSEcCtD
Zafirlukast—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00022	0.0013	CcSEcCtD
Zafirlukast—Malaise—Methotrexate—multiple sclerosis	0.000219	0.00129	CcSEcCtD
Zafirlukast—Urticaria—Dexamethasone—multiple sclerosis	0.000216	0.00127	CcSEcCtD
Zafirlukast—Urticaria—Betamethasone—multiple sclerosis	0.000216	0.00127	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000216	0.00127	CcSEcCtD
Zafirlukast—Dizziness—Prednisolone—multiple sclerosis	0.000216	0.00127	CcSEcCtD
Zafirlukast—Asthenia—Triamcinolone—multiple sclerosis	0.000215	0.00126	CcSEcCtD
Zafirlukast—Abdominal pain—Betamethasone—multiple sclerosis	0.000215	0.00126	CcSEcCtD
Zafirlukast—Body temperature increased—Dexamethasone—multiple sclerosis	0.000215	0.00126	CcSEcCtD
Zafirlukast—Body temperature increased—Betamethasone—multiple sclerosis	0.000215	0.00126	CcSEcCtD
Zafirlukast—Abdominal pain—Dexamethasone—multiple sclerosis	0.000215	0.00126	CcSEcCtD
Zafirlukast—Asthenia—Methylprednisolone—multiple sclerosis	0.000215	0.00126	CcSEcCtD
Zafirlukast—Insomnia—Prednisone—multiple sclerosis	0.000214	0.00126	CcSEcCtD
Zafirlukast—Pruritus—Triamcinolone—multiple sclerosis	0.000212	0.00125	CcSEcCtD
Zafirlukast—Pruritus—Methylprednisolone—multiple sclerosis	0.000212	0.00124	CcSEcCtD
Zafirlukast—Dyspepsia—Prednisone—multiple sclerosis	0.000209	0.00123	CcSEcCtD
Zafirlukast—Myalgia—Methotrexate—multiple sclerosis	0.000207	0.00121	CcSEcCtD
Zafirlukast—Arthralgia—Methotrexate—multiple sclerosis	0.000207	0.00121	CcSEcCtD
Zafirlukast—Rash—Prednisolone—multiple sclerosis	0.000206	0.00121	CcSEcCtD
Zafirlukast—Dermatitis—Prednisolone—multiple sclerosis	0.000205	0.00121	CcSEcCtD
Zafirlukast—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000205	0.0012	CcSEcCtD
Zafirlukast—Fatigue—Prednisone—multiple sclerosis	0.000204	0.0012	CcSEcCtD
Zafirlukast—Headache—Prednisolone—multiple sclerosis	0.000204	0.0012	CcSEcCtD
Zafirlukast—Discomfort—Methotrexate—multiple sclerosis	0.000204	0.0012	CcSEcCtD
Zafirlukast—Dizziness—Triamcinolone—multiple sclerosis	0.000198	0.00117	CcSEcCtD
Zafirlukast—Dizziness—Methylprednisolone—multiple sclerosis	0.000198	0.00116	CcSEcCtD
Zafirlukast—Infection—Methotrexate—multiple sclerosis	0.000197	0.00116	CcSEcCtD
Zafirlukast—Feeling abnormal—Prednisone—multiple sclerosis	0.000195	0.00115	CcSEcCtD
Zafirlukast—Asthenia—Betamethasone—multiple sclerosis	0.000195	0.00115	CcSEcCtD
Zafirlukast—Asthenia—Dexamethasone—multiple sclerosis	0.000195	0.00115	CcSEcCtD
Zafirlukast—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000194	0.00114	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000194	0.00114	CcSEcCtD
Zafirlukast—Nausea—Prednisolone—multiple sclerosis	0.000194	0.00114	CcSEcCtD
Zafirlukast—Pruritus—Betamethasone—multiple sclerosis	0.000193	0.00113	CcSEcCtD
Zafirlukast—Pruritus—Dexamethasone—multiple sclerosis	0.000193	0.00113	CcSEcCtD
Zafirlukast—Vomiting—Triamcinolone—multiple sclerosis	0.000191	0.00112	CcSEcCtD
Zafirlukast—Vomiting—Methylprednisolone—multiple sclerosis	0.00019	0.00112	CcSEcCtD
Zafirlukast—Rash—Triamcinolone—multiple sclerosis	0.000189	0.00111	CcSEcCtD
Zafirlukast—Dermatitis—Triamcinolone—multiple sclerosis	0.000189	0.00111	CcSEcCtD
Zafirlukast—Rash—Methylprednisolone—multiple sclerosis	0.000189	0.00111	CcSEcCtD
Zafirlukast—Dermatitis—Methylprednisolone—multiple sclerosis	0.000189	0.00111	CcSEcCtD
Zafirlukast—Urticaria—Prednisone—multiple sclerosis	0.000188	0.00111	CcSEcCtD
Zafirlukast—Headache—Triamcinolone—multiple sclerosis	0.000188	0.0011	CcSEcCtD
Zafirlukast—Headache—Methylprednisolone—multiple sclerosis	0.000187	0.0011	CcSEcCtD
Zafirlukast—Abdominal pain—Prednisone—multiple sclerosis	0.000187	0.0011	CcSEcCtD
Zafirlukast—Body temperature increased—Prednisone—multiple sclerosis	0.000187	0.0011	CcSEcCtD
Zafirlukast—Diarrhoea—Dexamethasone—multiple sclerosis	0.000186	0.00109	CcSEcCtD
Zafirlukast—Diarrhoea—Betamethasone—multiple sclerosis	0.000186	0.00109	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00018	0.00106	CcSEcCtD
Zafirlukast—Dizziness—Betamethasone—multiple sclerosis	0.00018	0.00106	CcSEcCtD
Zafirlukast—Dizziness—Dexamethasone—multiple sclerosis	0.00018	0.00106	CcSEcCtD
Zafirlukast—Insomnia—Methotrexate—multiple sclerosis	0.000179	0.00105	CcSEcCtD
Zafirlukast—Nausea—Triamcinolone—multiple sclerosis	0.000178	0.00105	CcSEcCtD
Zafirlukast—Nausea—Methylprednisolone—multiple sclerosis	0.000178	0.00104	CcSEcCtD
Zafirlukast—Hypersensitivity—Prednisone—multiple sclerosis	0.000175	0.00103	CcSEcCtD
Zafirlukast—Dyspepsia—Methotrexate—multiple sclerosis	0.000174	0.00102	CcSEcCtD
Zafirlukast—Vomiting—Dexamethasone—multiple sclerosis	0.000173	0.00102	CcSEcCtD
Zafirlukast—Vomiting—Betamethasone—multiple sclerosis	0.000173	0.00102	CcSEcCtD
Zafirlukast—Rash—Betamethasone—multiple sclerosis	0.000172	0.00101	CcSEcCtD
Zafirlukast—Rash—Dexamethasone—multiple sclerosis	0.000172	0.00101	CcSEcCtD
Zafirlukast—Dermatitis—Dexamethasone—multiple sclerosis	0.000171	0.00101	CcSEcCtD
Zafirlukast—Dermatitis—Betamethasone—multiple sclerosis	0.000171	0.00101	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000171	0.00101	CcSEcCtD
Zafirlukast—Fatigue—Methotrexate—multiple sclerosis	0.000171	0.001	CcSEcCtD
Zafirlukast—Headache—Betamethasone—multiple sclerosis	0.00017	0.001	CcSEcCtD
Zafirlukast—Headache—Dexamethasone—multiple sclerosis	0.00017	0.001	CcSEcCtD
Zafirlukast—Asthenia—Prednisone—multiple sclerosis	0.00017	0.000999	CcSEcCtD
Zafirlukast—Pain—Methotrexate—multiple sclerosis	0.000169	0.000996	CcSEcCtD
Zafirlukast—Pruritus—Prednisone—multiple sclerosis	0.000168	0.000986	CcSEcCtD
Zafirlukast—Feeling abnormal—Methotrexate—multiple sclerosis	0.000163	0.000959	CcSEcCtD
Zafirlukast—Diarrhoea—Prednisone—multiple sclerosis	0.000162	0.000953	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000162	0.000952	CcSEcCtD
Zafirlukast—Nausea—Dexamethasone—multiple sclerosis	0.000162	0.00095	CcSEcCtD
Zafirlukast—Nausea—Betamethasone—multiple sclerosis	0.000162	0.00095	CcSEcCtD
Zafirlukast—Urticaria—Methotrexate—multiple sclerosis	0.000157	0.000925	CcSEcCtD
Zafirlukast—Dizziness—Prednisone—multiple sclerosis	0.000157	0.000921	CcSEcCtD
Zafirlukast—Abdominal pain—Methotrexate—multiple sclerosis	0.000157	0.00092	CcSEcCtD
Zafirlukast—Body temperature increased—Methotrexate—multiple sclerosis	0.000157	0.00092	CcSEcCtD
Zafirlukast—Vomiting—Prednisone—multiple sclerosis	0.000151	0.000886	CcSEcCtD
Zafirlukast—Rash—Prednisone—multiple sclerosis	0.000149	0.000878	CcSEcCtD
Zafirlukast—Dermatitis—Prednisone—multiple sclerosis	0.000149	0.000877	CcSEcCtD
Zafirlukast—Headache—Prednisone—multiple sclerosis	0.000148	0.000873	CcSEcCtD
Zafirlukast—Hypersensitivity—Methotrexate—multiple sclerosis	0.000146	0.000858	CcSEcCtD
Zafirlukast—Asthenia—Methotrexate—multiple sclerosis	0.000142	0.000835	CcSEcCtD
Zafirlukast—Nausea—Prednisone—multiple sclerosis	0.000141	0.000827	CcSEcCtD
Zafirlukast—Pruritus—Methotrexate—multiple sclerosis	0.00014	0.000824	CcSEcCtD
Zafirlukast—Diarrhoea—Methotrexate—multiple sclerosis	0.000136	0.000797	CcSEcCtD
Zafirlukast—Dizziness—Methotrexate—multiple sclerosis	0.000131	0.00077	CcSEcCtD
Zafirlukast—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	0.000126	0.00132	CbGpPWpGaD
Zafirlukast—Vomiting—Methotrexate—multiple sclerosis	0.000126	0.00074	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000125	0.00131	CbGpPWpGaD
Zafirlukast—Rash—Methotrexate—multiple sclerosis	0.000125	0.000734	CcSEcCtD
Zafirlukast—Dermatitis—Methotrexate—multiple sclerosis	0.000125	0.000733	CcSEcCtD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000124	0.0013	CbGpPWpGaD
Zafirlukast—Headache—Methotrexate—multiple sclerosis	0.000124	0.000729	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL3—multiple sclerosis	0.000122	0.00127	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000121	0.00127	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00012	0.00126	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.00012	0.00126	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000118	0.00124	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000118	0.00124	CbGpPWpGaD
Zafirlukast—Nausea—Methotrexate—multiple sclerosis	0.000118	0.000691	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000117	0.00123	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000117	0.00123	CbGpPWpGaD
Zafirlukast—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000117	0.00123	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—RGS1—multiple sclerosis	0.000116	0.00122	CbGpPWpGaD
Zafirlukast—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000115	0.00121	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL5—multiple sclerosis	0.000113	0.00119	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000113	0.00119	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000113	0.00118	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000112	0.00117	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000111	0.00116	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—GPR65—multiple sclerosis	0.00011	0.00116	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR2—multiple sclerosis	0.00011	0.00115	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000109	0.00115	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000108	0.00113	CbGpPWpGaD
Zafirlukast—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000108	0.00113	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—POMC—multiple sclerosis	0.000108	0.00113	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000106	0.00111	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR ligand binding—CCL2—multiple sclerosis	0.000106	0.00111	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL3—multiple sclerosis	0.000104	0.00109	CbGpPWpGaD
Zafirlukast—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000103	0.00108	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCR5—multiple sclerosis	0.000102	0.00107	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CNR1—multiple sclerosis	0.000101	0.00106	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR1—multiple sclerosis	0.000101	0.00106	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL13—multiple sclerosis	0.000101	0.00106	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000101	0.00106	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000101	0.00105	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTGER4—multiple sclerosis	9.97e-05	0.00105	CbGpPWpGaD
Zafirlukast—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	9.85e-05	0.00103	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PGR—multiple sclerosis	9.82e-05	0.00103	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	9.75e-05	0.00102	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCR3—multiple sclerosis	9.63e-05	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CD28—multiple sclerosis	9.54e-05	0.001	CbGpPWpGaD
Zafirlukast—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.46e-05	0.000993	CbGpPWpGaD
Zafirlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.38e-05	0.000984	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR2—multiple sclerosis	9.37e-05	0.000982	CbGpPWpGaD
Zafirlukast—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.35e-05	0.00098	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CXCL10—multiple sclerosis	9.13e-05	0.000958	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—POMC—multiple sclerosis	8.79e-05	0.000922	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCL5—multiple sclerosis	8.66e-05	0.000908	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CNR1—multiple sclerosis	8.65e-05	0.000907	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SRM—multiple sclerosis	8.63e-05	0.000905	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.47e-05	0.000889	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.47e-05	0.000889	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.37e-05	0.000878	CbGpPWpGaD
Zafirlukast—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.34e-05	0.000875	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	8.31e-05	0.000872	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SRM—multiple sclerosis	8.29e-05	0.00087	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	8.25e-05	0.000865	CbGpPWpGaD
Zafirlukast—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.02e-05	0.000841	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—POMC—multiple sclerosis	7.99e-05	0.000838	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL5—multiple sclerosis	7.86e-05	0.000825	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CCL2—multiple sclerosis	7.81e-05	0.00082	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CCR5—multiple sclerosis	7.8e-05	0.000818	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CXCL10—multiple sclerosis	7.78e-05	0.000816	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2RA—multiple sclerosis	7.69e-05	0.000806	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—POMC—multiple sclerosis	7.69e-05	0.000806	CbGpPWpGaD
Zafirlukast—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.67e-05	0.000805	CbGpPWpGaD
Zafirlukast—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.61e-05	0.000798	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.56e-05	0.000793	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.56e-05	0.000793	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.4e-05	0.000776	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	7.36e-05	0.000772	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	7.33e-05	0.000769	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL3—multiple sclerosis	7.18e-05	0.000753	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—TYK2—multiple sclerosis	7.1e-05	0.000744	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCR5—multiple sclerosis	7.08e-05	0.000743	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	7.07e-05	0.000742	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2RA—multiple sclerosis	6.98e-05	0.000732	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTGER4—multiple sclerosis	6.91e-05	0.000725	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.9e-05	0.000723	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.9e-05	0.000723	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CD86—multiple sclerosis	6.81e-05	0.000714	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PGR—multiple sclerosis	6.81e-05	0.000714	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL5—multiple sclerosis	6.7e-05	0.000703	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCR3—multiple sclerosis	6.67e-05	0.0007	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CD28—multiple sclerosis	6.61e-05	0.000693	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—IL2—multiple sclerosis	6.5e-05	0.000682	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.5e-05	0.000682	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR2—multiple sclerosis	6.49e-05	0.000681	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SPP1—multiple sclerosis	6.21e-05	0.000651	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SRM—multiple sclerosis	6.2e-05	0.00065	CbGpPWpGaD
Zafirlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.19e-05	0.000649	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—POMC—multiple sclerosis	6.1e-05	0.000639	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP27B1—multiple sclerosis	6.08e-05	0.000638	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CYP24A1—multiple sclerosis	6.08e-05	0.000638	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCR5—multiple sclerosis	6.04e-05	0.000633	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CNR1—multiple sclerosis	5.99e-05	0.000628	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2RA—multiple sclerosis	5.95e-05	0.000624	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL2—multiple sclerosis	5.9e-05	0.000619	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.89e-05	0.000618	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.89e-05	0.000618	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP24A1—multiple sclerosis	5.84e-05	0.000613	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CYP27B1—multiple sclerosis	5.84e-05	0.000613	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—POMC—multiple sclerosis	5.74e-05	0.000602	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.73e-05	0.000601	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.72e-05	0.0006	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.71e-05	0.000599	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	5.71e-05	0.000599	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	5.61e-05	0.000588	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—GPC5—multiple sclerosis	5.56e-05	0.000583	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—POMC—multiple sclerosis	5.54e-05	0.000581	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—APOE—multiple sclerosis	5.49e-05	0.000576	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CCL2—multiple sclerosis	5.42e-05	0.000568	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CXCL10—multiple sclerosis	5.4e-05	0.000566	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SRM—multiple sclerosis	5.36e-05	0.000562	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—GPC5—multiple sclerosis	5.34e-05	0.00056	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	5.34e-05	0.00056	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	5.34e-05	0.00056	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.02e-05	0.000526	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CD80—multiple sclerosis	4.97e-05	0.000521	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.96e-05	0.000521	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TYK2—multiple sclerosis	4.92e-05	0.000516	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SRM—multiple sclerosis	4.78e-05	0.000501	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—POMC—multiple sclerosis	4.72e-05	0.000495	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CD86—multiple sclerosis	4.72e-05	0.000495	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL5—multiple sclerosis	4.64e-05	0.000487	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCL2—multiple sclerosis	4.62e-05	0.000484	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—RRM1—multiple sclerosis	4.61e-05	0.000483	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—MAPK1—multiple sclerosis	4.52e-05	0.000474	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—IL2—multiple sclerosis	4.51e-05	0.000473	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.43e-05	0.000465	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—RRM1—multiple sclerosis	4.43e-05	0.000464	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SRM—multiple sclerosis	4.4e-05	0.000461	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	4.37e-05	0.000458	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	4.37e-05	0.000458	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SRM—multiple sclerosis	4.36e-05	0.000457	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SPP1—multiple sclerosis	4.3e-05	0.000451	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TYK2—multiple sclerosis	4.19e-05	0.00044	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCR5—multiple sclerosis	4.18e-05	0.000439	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2RA—multiple sclerosis	4.12e-05	0.000432	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL2—multiple sclerosis	4.09e-05	0.000429	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—POMC—multiple sclerosis	4.08e-05	0.000427	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.04e-05	0.000424	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.99e-05	0.000419	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—APOE—multiple sclerosis	3.81e-05	0.000399	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.77e-05	0.000396	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.77e-05	0.000396	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SRM—multiple sclerosis	3.73e-05	0.000391	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.69e-05	0.000387	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL2—multiple sclerosis	3.49e-05	0.000366	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—IL6—multiple sclerosis	3.47e-05	0.000364	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.45e-05	0.000362	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.45e-05	0.000362	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CD80—multiple sclerosis	3.44e-05	0.000361	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.44e-05	0.00036	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.37e-05	0.000353	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.37e-05	0.000353	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—RRM1—multiple sclerosis	3.31e-05	0.000347	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MMP9—multiple sclerosis	3.3e-05	0.000346	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.29e-05	0.000345	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—POMC—multiple sclerosis	3.27e-05	0.000343	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCL2—multiple sclerosis	3.2e-05	0.000336	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—MAPK1—multiple sclerosis	3.13e-05	0.000328	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	3.1e-05	0.000325	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	3.1e-05	0.000325	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.08e-05	0.000323	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.07e-05	0.000322	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.07e-05	0.000322	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3e-05	0.000315	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.95e-05	0.00031	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—STAT3—multiple sclerosis	2.93e-05	0.000308	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TYK2—multiple sclerosis	2.91e-05	0.000305	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SRM—multiple sclerosis	2.88e-05	0.000302	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.86e-05	0.0003	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.83e-05	0.000297	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.81e-05	0.000295	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MYC—multiple sclerosis	2.73e-05	0.000286	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TGFB1—multiple sclerosis	2.72e-05	0.000285	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.69e-05	0.000282	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MAPK1—multiple sclerosis	2.67e-05	0.00028	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.66e-05	0.000279	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.66e-05	0.000279	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—BCHE—multiple sclerosis	2.65e-05	0.000278	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.62e-05	0.000275	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.62e-05	0.000275	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.57e-05	0.000269	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.55e-05	0.000268	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—BCHE—multiple sclerosis	2.54e-05	0.000267	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL2—multiple sclerosis	2.42e-05	0.000254	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—IL6—multiple sclerosis	2.41e-05	0.000252	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.4e-05	0.000252	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.35e-05	0.000246	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.33e-05	0.000244	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MMP9—multiple sclerosis	2.29e-05	0.00024	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.22e-05	0.000233	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—IL6—multiple sclerosis	2.05e-05	0.000215	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—STAT3—multiple sclerosis	2.03e-05	0.000213	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.03e-05	0.000212	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.03e-05	0.000212	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.99e-05	0.000209	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.98e-05	0.000208	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.91e-05	0.0002	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.9e-05	0.000199	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MYC—multiple sclerosis	1.89e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TGFB1—multiple sclerosis	1.89e-05	0.000198	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.85e-05	0.000194	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MAPK1—multiple sclerosis	1.85e-05	0.000194	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.81e-05	0.000189	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.74e-05	0.000182	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.7e-05	0.000178	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.64e-05	0.000172	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—APOE—multiple sclerosis	1.59e-05	0.000167	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.55e-05	0.000163	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.55e-05	0.000163	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.54e-05	0.000162	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.54e-05	0.000161	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—APOE—multiple sclerosis	1.53e-05	0.00016	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.47e-05	0.000154	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—IL6—multiple sclerosis	1.42e-05	0.000149	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.41e-05	0.000148	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—POMC—multiple sclerosis	1.37e-05	0.000143	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.35e-05	0.000141	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.00014	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.33e-05	0.000139	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—POMC—multiple sclerosis	1.31e-05	0.000138	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—ALB—multiple sclerosis	1.25e-05	0.000131	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.21e-05	0.000127	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—ALB—multiple sclerosis	1.2e-05	0.000126	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—APOE—multiple sclerosis	1.14e-05	0.00012	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.00012	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—APOE—multiple sclerosis	9.88e-06	0.000104	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—POMC—multiple sclerosis	9.82e-06	0.000103	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—ALB—multiple sclerosis	8.95e-06	9.39e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—APOE—multiple sclerosis	8.82e-06	9.25e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—BCHE—multiple sclerosis	8.82e-06	9.25e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—POMC—multiple sclerosis	8.49e-06	8.9e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—APOE—multiple sclerosis	8.11e-06	8.51e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—APOE—multiple sclerosis	8.04e-06	8.44e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—ALB—multiple sclerosis	7.74e-06	8.12e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—POMC—multiple sclerosis	7.58e-06	7.95e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—POMC—multiple sclerosis	6.97e-06	7.31e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—POMC—multiple sclerosis	6.91e-06	7.25e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—ALB—multiple sclerosis	6.91e-06	7.25e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—APOE—multiple sclerosis	6.87e-06	7.21e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—ALB—multiple sclerosis	6.35e-06	6.66e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—ALB—multiple sclerosis	6.3e-06	6.61e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—POMC—multiple sclerosis	5.9e-06	6.19e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—ALB—multiple sclerosis	5.38e-06	5.65e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—APOE—multiple sclerosis	5.3e-06	5.56e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—POMC—multiple sclerosis	4.56e-06	4.78e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—ALB—multiple sclerosis	4.15e-06	4.36e-05	CbGpPWpGaD
